申请人:Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Rt.
公开号:US04324743A1
公开(公告)日:1982-04-13
A process for preparing gamma-L-glutamyl-taurine, which has been found to be effective therapeutically through the control of vitamin A metabolism, which comprises reacting carbobenzyloxy-L-glutaminic acid-.alpha.-benzyl ester with triethylamine and isobutylchloroformate and then treating the reaction mixture with cystamine dihydrochloride to recover N,N'-bis-(N-carbobenzyloxy-gamma-[.alpha.-benzyl]-L-glutamyl)-cystamine. The latter is reacted with hydrogen peroxide in glacial acetic acid to produce carbobenzyloxy-gamma-(.alpha.-benzyl)-L-glutamyl taurine. The latter compound is treated with hydrogen bromide in glacial acetic acid to recover the gamma-(.alpha.-benzyl)-L-glutamyl taurine and this compound is treated with potassium hydroxide solution to yield the gamma-L-glutamyl taurine.
Substituted glutaurine compounds and substituted glutaurine derivatives
申请人:ThermoLife International, LLC
公开号:US09662304B1
公开(公告)日:2017-05-30
The present invention is directed to compositions and dietary supplements comprising the following compound
本发明涉及包含以下化合物的组合物和膳食补充剂。
Glutaurine compositions and therapeutic uses thereof
申请人:ThermoLife International, LLC
公开号:US10420739B1
公开(公告)日:2019-09-24
The present disclosure provides compositions and methods useful for the treatment of a body weight condition or a thyroid disorder. The compositions induces increased T3 levels while preventing thyroidal atrophy. Also provided are compositions and methods for the treatment of a disease or condition that is estrogen sensitive, estrogen receptor dependent or estrogen receptor mediated such as breast cancer.